HIGHLIGHTS
- who: Hamid Reza Jahantigh and colleagues from the Interdisciplinary Department of Medicine, Section of Occupational Medicine, University of Bari, Bari, Italy have published the Article: Recombinant GPEHT Fusion Protein Derived from HTLV-1 Proteins with Alum Adjuvant Induces a High Immune Response in Mice, in the Journal: Vaccines 2023, 115 of /2023/
- what: The authors assessed the potential of a multi-epitope vaccine candidate for stimulating the immune response against HTLV-1. Based on the previous report and unlike the previous candidate vaccine, which relied on a portion of the HTLV-1 genome, in this . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.